BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38296564)

  • 1. Astaxanthin Alleviates the Process of Cardiac Hypertrophy by Targeting the METTL3/Circ_0078450/MiR-338-3p/GATA4 Pathway.
    Zhang K; Zhuo H; Guo J; Wang W; Dai R
    Int Heart J; 2024; 65(1):119-127. PubMed ID: 38296564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner.
    Zhang R; Qu Y; Ji Z; Hao C; Su Y; Yao Y; Zuo W; Chen X; Yang M; Ma G
    Cell Mol Biol Lett; 2022 Jul; 27(1):55. PubMed ID: 35836108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel circ_0018553 protects against angiotensin-induced cardiac hypertrophy in cardiomyocytes by modulating the miR-4731/SIRT2 signaling pathway.
    Zuo H; Li L; Wang X; Chen S; Liao Z; Wei S; Ruan H; Li T; Chen J
    Hypertens Res; 2023 Feb; 46(2):421-436. PubMed ID: 36474029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-133a-3p attenuates cardiomyocyte hypertrophy through inhibiting pyroptosis activation by targeting IKKε.
    Zhu YF; Wang R; Chen W; Cao YD; Li LP; Chen X
    Acta Histochem; 2021 Jan; 123(1):151653. PubMed ID: 33246224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
    Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA circ_0001006 aggravates cardiac hypertrophy via miR-214-3p/PAK6 axis.
    Lin X; Zhang L; Zhang W; Lei X; Lu Q; Ma A
    Aging (Albany NY); 2022 Mar; 14(5):2210-2220. PubMed ID: 35306484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA circRNA_000203 aggravates cardiac hypertrophy via suppressing miR-26b-5p and miR-140-3p binding to Gata4.
    Li H; Xu JD; Fang XH; Zhu JN; Yang J; Pan R; Yuan SJ; Zeng N; Yang ZZ; Yang H; Wang XP; Duan JZ; Wang S; Luo JF; Wu SL; Shan ZX
    Cardiovasc Res; 2020 Jun; 116(7):1323-1334. PubMed ID: 31397837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy.
    Tang CM; Liu FZ; Zhu JN; Fu YH; Lin QX; Deng CY; Hu ZQ; Yang H; Zheng XL; Cheng JD; Wu SL; Shan ZX
    Sci Rep; 2016 Oct; 6():36146. PubMed ID: 27796324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-410-3p facilitates Angiotensin II-induced cardiac hypertrophy by targeting Smad7.
    Jia G; Liang C; Li W; Dai H
    Bioengineered; 2022 Jan; 13(1):119-127. PubMed ID: 34951337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ_0020887 Silencing Combats Hypoxic-Induced Cardiomyocyte Injury in an MiR-370-3p/CYP1B1-Dependent Manner.
    Chen H; Cheng Z; Wang M; Huang Q; Zheng D; Huang Q; Cai K
    Int Heart J; 2024 Mar; 65(2):308-317. PubMed ID: 38479850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
    Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
    J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-26a protects against cardiac hypertrophy via inhibiting GATA4 in rat model and cultured cardiomyocytes.
    Liu Y; Wang Z; Xiao W
    Mol Med Rep; 2016 Sep; 14(3):2860-6. PubMed ID: 27485101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0010729 regulates hypoxia-induced cardiomyocyte injuries by activating TRAF5 via sponging miR-27a-3p.
    Lei D; Wang Y; Zhang L; Wang Z
    Life Sci; 2020 Dec; 262():118511. PubMed ID: 33010282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircRNA Larp4b/miR-298-5p/Mef2c Regulates Cardiac Hypertrophy Induced by Angiotensin II.
    Xie Q; Xu X; Xiong D; Yao M; Zhou Y
    Int J Sports Med; 2024 Jan; 45(1):33-40. PubMed ID: 37956874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. circ_0023461 Silencing Protects Cardiomyocytes from Hypoxia-Induced Dysfunction through Targeting miR-370-3p/PDE4D Signaling.
    Ren K; Li B; Jiang L; Liu Z; Wu F; Zhang Y; Liu J; Duan W
    Oxid Med Cell Longev; 2021; 2021():8379962. PubMed ID: 34630853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2.
    Wang N; Frank GD; Ding R; Tan Z; Rachakonda A; Pandolfi PP; Senbonmatsu T; Landon EJ; Inagami T
    PLoS One; 2012; 7(4):e35632. PubMed ID: 22558183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
    Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
    Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
    Lu P; Xu Y; Sheng ZY; Peng XG; Zhang JJ; Wu QH; Wu YQ; Cheng XS; Zhu K
    Exp Cell Res; 2021 Sep; 406(1):112761. PubMed ID: 34339675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of circHIPK3 Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction by Sponging miR-185-3p.
    Xu X; Wang J; Wang X
    Drug Des Devel Ther; 2020; 14():5699-5710. PubMed ID: 33402817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has_circ_0008583 modulates hepatocellular carcinoma progression through the miR-1301-3p/METTL3 pathway.
    Wang F; Xie Z; Zhang N; Ding H; Xiong K; Guo L; Huang H; Wen Z
    Bioengineered; 2022 Jan; 13(1):1185-1197. PubMed ID: 35258395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.